Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study ; volume:162 ; number:3 ; day:7 ; month:2 ; year:2017 ; pages:479-488 ; date:4.2017
Breast cancer research and treatment ; 162, Heft 3 (7.2.2017), 479-488, 4.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Higgins, M.
- Contributor
-
Curigliano, G.
Dieras, V.
Kuemmel, S.
Kunz, G.
Fasching, P. A.
Campone, M.
Bachelot, T.
Krivorotko, P.
Chan, S.
Ferro, A.
Schwartzberg, L.
Gillet, M.
Sousa Alves, P. M. De
Wascotte, V.
Lehmann, F. F.
Goss, P.
SpringerLink (Online service)
- DOI
-
10.1007/s10549-017-4130-y
- URN
-
urn:nbn:de:1111-2017032311557
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Higgins, M.
- Curigliano, G.
- Dieras, V.
- Kuemmel, S.
- Kunz, G.
- Fasching, P. A.
- Campone, M.
- Bachelot, T.
- Krivorotko, P.
- Chan, S.
- Ferro, A.
- Schwartzberg, L.
- Gillet, M.
- Sousa Alves, P. M. De
- Wascotte, V.
- Lehmann, F. F.
- Goss, P.
- SpringerLink (Online service)
Other Objects (12)
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie